enVVeno Medical (@envvenomedical) 's Twitter Profile
enVVeno Medical

@envvenomedical

enVVeno Medical ( $NVNO ) is a late clinical-stage medical device company focused on setting new standards of care for the treatment of #VenousDisease.

ID: 1097586896702648325

linkhttps://envveno.com/ calendar_today18-02-2019 20:01:23

469 Tweet

649 Followers

455 Following

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

We’re headed to New Orleans for #VAM25 hosted by Society for Vascular Surgery. We look forward to sharing insights and learning about the latest in vascular medicine from our colleagues across the industry. Stop by booth 452 for more information. $NVNO #DeepVenousDisease

We’re headed to New Orleans for #VAM25 hosted by <a href="/VascularSVS/">Society for Vascular Surgery</a>. We look forward to sharing insights and learning about the latest in vascular medicine from our colleagues across the industry. Stop by booth 452 for more information.

$NVNO #DeepVenousDisease
enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Join us tomorrow, live from #VAM25, for a webcast featuring Robert Berman, enVVeno CEO, and Dr. Cassius Chaar of Yale University. Register at us02web.zoom.us/webinar/regist… $NVNO #DeepVenousDisease #ChronicVenousInsufficiency #CVI

Join us tomorrow, live from #VAM25, for a webcast featuring Robert Berman, enVVeno CEO, and Dr. Cassius Chaar of Yale University.

Register at us02web.zoom.us/webinar/regist…

$NVNO #DeepVenousDisease #ChronicVenousInsufficiency #CVI
enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Interim 2-Year Data from enVVeno Medical’s Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting Read more: bit.ly/4kx1cYR $NVNO #VAM25 #DeepVenousDisease #ChronicVenousInsufficiency #CVI

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Today at #VAM25, Dr. Cassius Iyad Ochoa Chaar, Associate Professor of Surgery, Yale University School of Medicine, will present updates on clinical improvements on patients with #deepvenousreflux, 2 years after the implantation of our investigative therapy for severe #CVI. $NVNO

Today at #VAM25, Dr. Cassius Iyad Ochoa Chaar, Associate Professor of Surgery, Yale University School of Medicine, will present updates on clinical improvements on patients with #deepvenousreflux, 2 years after the implantation of our investigative therapy for severe #CVI.

$NVNO
enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

From filming with our KOLs to presenting our 2-year interim pivotal study data, we had a great time in New Orleans at #VAM25! Can't wait to see what's in store for next year. Check out photos from our time there below and learn more about our data here: bit.ly/4kSZj8w

From filming with our KOLs to presenting our 2-year interim pivotal study data, we had a great time in New Orleans at #VAM25! Can't wait to see what's in store for next year. 
 
Check out photos from our time there below and learn more about our data here: bit.ly/4kSZj8w
enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Listen to our CEO, Robert Berman, on why #CVI occurs and how it affects venous valves. $NVNO #DeepVenousDisease #ChronicVenousInsufficiency

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

From panels to presentations to livestream webinars, so far 2025 has been a full slate! It’s been a privilege to share how we’re working to redefine treatment for severe deep venous #chronicvenousinsufficiency. Check out photos from these events below $NVNO #DeepVenousDisease

From panels to presentations to livestream webinars, so far 2025 has been a full slate! It’s been a privilege to share how we’re working to redefine treatment for severe deep venous #chronicvenousinsufficiency.

Check out photos from these events below

$NVNO #DeepVenousDisease
enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

#ChronicVenousInsufficiency impacts millions of people in the U.S., including the #POTUS. Our Chief Medical Officer, Marc Glickman, shared his insight with LiveNOW from FOX on the President’s recent diagnosis and the unmet need of those living with #CVI. Watch the full segment at

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Last week we spoke with Fox News @ Night about the prevalence and unmet need of those suffering from #ChronicVenousInsufficiency and the symptoms and challenges that can accompany this challenging and serious disease once it has progressed to a more severe state. At enVVeno, we are

Virtual Investor Co. (@investorvirtual) 's Twitter Profile Photo

Rob Berman, CEO of @enVVenomedical, shares how enVVeno is setting new expectations in venous care in the Virtual Investor Summer Spotlight On Demand Conference. Access it here: vimeo.com/1103248970/74b… $NVNO

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Vascular surgeon Dr. David Dexter recently spoke with Newsweek about the current lack of treatment options for those living with #ChronicVenousInsufficiency and our investigational treatment for severe #CVI. Read more: newsweek.com/donald-trump-h…

Virtual Investor Co. (@investorvirtual) 's Twitter Profile Photo

enVVeno Medical participated in Virtual Investor’s What This Means segment to discuss the rising awareness of CVI following President Trump’s diagnosis and the potential impact of enVVeno. Access the segment to learn more: vimeo.com/1107075148/728… $NVNO enVVeno Medical President Donald J. Trump

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

WATCH LIVE: We announced preliminary findings from a health economic study showing that our investigational therapy may be a cost-effective treatment option for patients with severe Chronic Venous Insufficiency (CVI) caused by deep valvular incompetency. 📅 Join today’s webcast

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

#ICYMI Last week we joined Virtual Investor Co.’s “What This Means” segment to discuss the rising public attention of #ChronicVenousInsufficiency (#CVI) - including the President’s recent diagnosis. As we continue working on addressing this unmet need, we are encouraged by the

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

We’re turning the spotlight on our CFO, Jennifer Bright, who came to enVVeno earlier this year and we couldn’t be happier! Learn a bit more about her below. Thank you, Jennifer, for all you do. $NVNO #CVI #ChronicVenousInsufficiency #CompanyCulture

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

#ChronicVenousInsufficiency isn’t commonly discussed, but that doesn’t mean it isn’t extremely prevalent. Our CEO, Robert Berman, recently shared his thoughts with Virtual Investor Co. on the millions of people in the U.S. suffering from this crippling disease. #CVI #VenousDisease

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

There are multiple signs and symptoms to assess when diagnosing severe deep #ChronicVenousInsufficiency. Dr. Marc Glickman breaks it down below. #CVI #VenousDisease

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Today we announced that our CEO, Robert Berman, will be presenting at the upcoming Webull Corporate Connect Webinar Series on Thursday, August 21 at 2:00pm ET. For more information and to register visit envveno.com/envveno-medica… #biotech #chronicvenousinsufficiency #CVI

enVVeno Medical (@envvenomedical) 's Twitter Profile Photo

Today, we shared an update on the FDA’s decision on our VenoValve for the treatment of severe deep #CVI. Read more here: bit.ly/45qEBYL

Today, we shared an update on the FDA’s decision on our VenoValve for the treatment of severe deep #CVI.

Read more here: bit.ly/45qEBYL